We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

Molecular Diagnostics

Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

A study has uncovered new biomarkers in renal cell carcinomas that could enhance the accuracy of diagnoses and potentially improve treatment strategies for the disease. More...
10 May 2024
Image: ColoSense is the first FDA-approved RNA-based molecular screening test for qualitative detection of colorectal cancer (Photo courtesy of Geneoscopy)

RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer

The U.S. FDA has approved a noninvasive screening test for colorectal cancer for adults, 45 years of age or older, who are at typical average risk of developing the disease. More...
10 May 2024
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

A groundbreaking study offers new hope for not only earlier diagnosis but also for potentially slowing the course of Alzheimer’s disease. More...
08 May 2024
Image: AssureMDx is a noninvasive, urine-based test for the early detection of bladder cancer (Photo courtesy of Lightspring/Shutterstock)

Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection

A novel noninvasive urine-based test promises to more accurately identify patients who are at high risk of bladder cancer and would benefit from a urological evaluation. More...
08 May 2024
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

BioVendor MDx has introduced the first commercial NGS assay specifically for the detection of BCR::ABL1 fusion gene which plays a key role in the pathogenesis of several blood cancers. More...
06 May 2024
Image: Urine testing could revolutionize Lyme disease detection and diagnosis (Credit: Silver Place/Shutterstock)

Urine Test to Revolutionize Lyme Disease Testing

Urine testing could revolutionize Lyme disease detection and diagnosis due to its advantages over existing antibody blood tests that detect the immune system's response to the bacteria responsible for the disease. More...
03 May 2024
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

A simple blood test offers the potential for doctors to identify individuals at increased risk for stroke or cognitive decline by measuring levels of a network of inflammatory molecules. More...
02 May 2024
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Magnetic Bead Separation Modules

Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2024 Globetech Media. All rights reserved.